Study area | Remitting–relapsing (%) | Monophasic (%) | Chronic (%) |
New South Wales11 | 51 | – | 49* |
SE England12† | 43 | 13 | 37 |
Vest-Agder, Norway13 | 33 | 6 | 61 |
Piemonte, Italy | 26 | 12 | 62 |
*Includes all non-remitting–relapsing forms.
†7% of cases were classified as relapsing Guillain–Barré syndrome.